Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,962 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ivermectin Inhibits HBV Entry into the Nucleus by Suppressing KPNA2.
Nakanishi A, Okumura H, Hashita T, Yamashita A, Nishimura Y, Watanabe C, Kamimura S, Hayashi S, Murakami S, Ito K, Iwao T, Ikeda A, Hirose T, Sunazuka T, Tanaka Y, Matsunaga T. Nakanishi A, et al. Among authors: murakami s. Viruses. 2022 Nov 8;14(11):2468. doi: 10.3390/v14112468. Viruses. 2022. PMID: 36366568 Free PMC article.
Characterization of novel entecavir resistance mutations.
Hayashi S, Murakami S, Omagari K, Matsui T, Iio E, Isogawa M, Watanabe T, Karino Y, Tanaka Y. Hayashi S, et al. Among authors: murakami s. J Hepatol. 2015 Sep;63(3):546-53. doi: 10.1016/j.jhep.2015.03.020. Epub 2015 Mar 25. J Hepatol. 2015. PMID: 25817219
CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus.
Higashi-Kuwata N, Hayashi S, Das D, Kohgo S, Murakami S, Hattori SI, Imoto S, Venzon DJ, Singh K, Sarafianos SG, Tanaka Y, Mitsuya H. Higashi-Kuwata N, et al. Among authors: murakami s. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02143-18. doi: 10.1128/AAC.02143-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670420 Free PMC article.
7-Deaza-7-fluoro modification confers on 4'-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety.
Hayashi S, Higashi-Kuwata N, Das D, Tomaya K, Yamada K, Murakami S, Venzon DJ, Hattori SI, Isogawa M, Sarafianos SG, Mitsuya H, Tanaka Y. Hayashi S, et al. Among authors: murakami s. Antiviral Res. 2020 Apr;176:104744. doi: 10.1016/j.antiviral.2020.104744. Epub 2020 Feb 18. Antiviral Res. 2020. PMID: 32084506 Free PMC article.
4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.
Takamatsu Y, Tanaka Y, Kohgo S, Murakami S, Singh K, Das D, Venzon DJ, Amano M, Higashi-Kuwata N, Aoki M, Delino NS, Hayashi S, Takahashi S, Sukenaga Y, Haraguchi K, Sarafianos SG, Maeda K, Mitsuya H. Takamatsu Y, et al. Among authors: murakami s. Hepatology. 2015 Oct;62(4):1024-36. doi: 10.1002/hep.27962. Epub 2015 Aug 25. Hepatology. 2015. PMID: 26122273 Free PMC article.
Property of hepatitis B virus replication in Tupaia belangeri hepatocytes.
Sanada T, Tsukiyama-Kohara K, Yamamoto N, Ezzikouri S, Benjelloun S, Murakami S, Tanaka Y, Tateno C, Kohara M. Sanada T, et al. Among authors: murakami s. Biochem Biophys Res Commun. 2016 Jan 8;469(2):229-35. doi: 10.1016/j.bbrc.2015.11.121. Epub 2015 Nov 30. Biochem Biophys Res Commun. 2016. PMID: 26654952 Free article.
Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
Tanaka T, Okuyama-Dobashi K, Murakami S, Chen W, Okamoto T, Ueda K, Hosoya T, Matsuura Y, Ryo A, Tanaka Y, Hagiwara M, Moriishi K. Tanaka T, et al. Among authors: murakami s. Antiviral Res. 2016 Sep;133:156-64. doi: 10.1016/j.antiviral.2016.08.008. Epub 2016 Aug 8. Antiviral Res. 2016. PMID: 27515132
2,962 results